Pamela Anne Baker, RN in Bellows Falls, VT - Registered Nurse

Pamela Anne Baker, RN is a Registered Nurse based in Bellows Falls, Vermont. Pamela Anne Baker is licensed to practice in Vermont (license number 0260043291) and her current practice location is 1 Hospital Ct, Suite 2, Bellows Falls, Vermont. She can be reached at her office (for appointments etc.) via phone at (802) 463-3532.

NPI number for Pamela Anne Baker is 1184973612 and her current mailing address is 390 River St, Springfield, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1184973612.

Contact Information

	Pamela Anne Baker, RN
	1 Hospital Ct, Suite 2, Bellows Falls, VT 05101-1489
	(802) 463-3532
	Not Available

Provider's Profile

Full Name	Pamela Anne Baker
Gender	Female
Speciality	Registered Nurse
Location	1 Hospital Ct, Bellows Falls, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1184973612
Provider Enumeration Date: 08/30/2012
Last Update Date: 08/30/2012

Medical Identifiers

Medical identifiers for Pamela Anne Baker such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1184973612	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163W00000X	Registered Nurse	0260043291 (Vermont)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Pamela Anne Baker is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Pamela Anne Baker, RN 390 River St, Springfield, VT 05156-2226 Ph: (802) 886-4567	Pamela Anne Baker, RN 1 Hospital Ct, Suite 2, Bellows Falls, VT 05101-1489 Ph: (802) 463-3532

News Archive

Researchers reveal potent new mechanism of action for treatment of IBD

Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.

Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy

Ferring Pharmaceuticals announced today the European launch of CORTIMENT®MMX® (budesonide), the first and only approved oral controlled release budesonide treatment for active mild-to-moderate ulcerative colitis (UC) where mesalazine (5-ASA) treatment is not sufficient.

FDA approves HUD designation for SynCardia temporary Total Artificial Heart for destination therapy

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant.

State highlights: Abortion coverage fight at a Catholic University In Calif.; N.C.'S Medicaid managed care plan attacts companies; some Calif. exchange rates uncertain

Trustees of the Jesuit [Loyola Marymount University] will decide on Monday whether to remove coverage for elective abortions from the faculty and staff health care plans. The coming vote has exposed a deep rift over just how Catholic a Catholic university should be in the 21st century - and how to maintain that distinctive Catholic identity amid growing diversity on campus (Lovett, 10/6).

Non-HDL-C levels appear to increase risk of heart attack or stroke in statin-treated patients

Levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin-treated patients appears to be associated with the risk of developing a major cardiovascular event, such as a heart attack or stroke, as are levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B, according to a meta-analysis of data from previously published studies appearing in the March 28 issue of JAMA.

Registered Nurse Nurses in Bellows Falls, VT

Cynthia S Lucius, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: One Hospital Court, Ste 410, Bellows Falls, VT 05101 Phone: 802-463-3294 Fax: 802-463-1206
Marissa Martin, PMHNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Ct, Bellows Falls, VT 05101 Phone: 802-463-2657
Dawne Ruot-jackson, ADN RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Court Suite 2, Bellows Falls, VT 05101 Phone: 802-463-3947 Fax: 802-463-1202

Pamela Anne Baker, RN - Registered Nurse in Bellows Falls, VT